Status:
COMPLETED
Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
25-75 years
Phase:
PHASE2
Brief Summary
Dendritic cells loaded with tumor antigens induce cytotoxic T-cells which have been proved capable of killing both melanoma and breast cancer cells. Melanoma and colorectal cancer cells express some c...
Eligibility Criteria
Inclusion
- Verified cancer of colon or rectum
- No chemo- or radiation therapy in 6 weeks
- Performance status 0, 1, or 2 (WHO criteria)
- Adequate function of the kidneys, liver, lungs, and heart
- Adequate function of the hematopoietic system and the coagulation system
- Negative pregnancy test and adequate birth control for fertile women
Exclusion
- Pregnancy
- Uncontrolled infection
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00311272
Start Date
November 1 2004
End Date
September 1 2007
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surgical Department, University Hospital Gentofte
Hellerup, Denmark, 2900